Academic Bibliography

Search 200 years of publications by Ghent University researchers.

prof. Vibeke Kruse

Faculty of Medicine and Health Sciences > Department of Internal Medicine and Pediatrics

Work address: C. Heymanslaan 10, ingang 12 - verdieping 6
9000 Gent
Email: VIBEKE.KRUSE@UGent.be

Show Sort by

Add to list
- Journal Article
- A1
- open access
Mental health and quality of life among patients with cancer during the SARS-CoV-2 pandemic : results from the longitudinal ONCOVID survey study

Emiel De Jaeghere (UGent) , Heini Kanervo (UGent) , Roos Colman (UGent) , Wim Schrauwen (UGent) , Paulien West (UGent) , Nele Vandemaele (UGent) , Aglaja De Pauw (UGent) , Celine Jacobs (UGent) , Ingeborg Hilderson, Michael Saerens (UGent) , et al.

(2022) CANCERS. 14(4).
Add to list
- Journal Article
- A1
- open access
Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial

Mathieu Spaas (UGent) , Nora Sundahl, Eva Hulstaert, Vibeke Kruse (UGent) , Sylvie Rottey (UGent) , Daan De Maeseneer (UGent) , Veerle Surmont (UGent) , Annabel Meireson (UGent) , Lieve Brochez (UGent) , Dries Reynders (UGent) , et al.

(2021) BMC CANCER. 21(1).
Add to list
- Journal Article
- A1
- open access
Immune monitoring in melanoma and urothelial cancer patients treated with anti-PD-1 immunotherapy and SBRT discloses tumor specific immune signatures

Annabel Meireson (UGent) , Simon Tavernier (UGent) , Sofie Van Gassen (UGent) , Nora Sundahl, Annelies Demeyer (UGent) , Mathieu Spaas (UGent) , Vibeke Kruse (UGent) , Liesbeth Ferdinande (UGent) , Jo Van Dorpe (UGent) , Benjamin Hennart, et al.

(2021) CANCERS. 13(11).
Add to list
Selective oral MEK1/2 inhibitor pimasertib : a phase I trial in patients with advanced solid tumors

Jean-Pierre Delord, Antoine Italiano, Ahmad Awada, Philippe Aftimos, Nadine Houédé, Céleste Lebbé, Celine Pages, Thierry Lesimple, Monica Dinulescu, Jan H. M. Schellens, et al.

(2021) TARGETED ONCOLOGY. 16(1). p.37-46
Add to list
Selective oral MEK1/2 inhibitor pimasertib in metastatic melanoma : antitumor activity in a phase I, dose-escalation trial

Céleste Lebbé, Antoine Italiano, Nadine Houédé, Ahmad Awada, Philippe Aftimos, Thierry Lesimple, Monica Dinulescu, Jan H. M. Schellens, Suzanne Leijen, Sylvie Rottey (UGent) , et al.

(2021) TARGETED ONCOLOGY. 16(1). p.47-57
Add to list
- Miscellaneous
Spatiotemporal evolution of radiation myositis on 18F-FDG PET/CT following hypofractionated radiotherapy of intramuscular melanoma metastases

Mathieu Spaas (UGent) , Bliede Van den Broeck (UGent) , David Creytens (UGent) , Vibeke Kruse (UGent) and Piet Ost (UGent)

(2021) CLINICAL NUCLEAR MEDICINE. 46(7). p.E384-E386
Add to list
Managing viral hepatitis in cancer patients under immune checkpoint inhibitors : should we take the risk?

Stijn De Keukeleire (UGent) , Tijl Vermassen (UGent) , Zahra Mosala Nezhad, Tessa Kerre (UGent) , Vibeke Kruse (UGent) , Hans Van Vlierberghe (UGent) , Karim Vermaelen (UGent) and Sylvie Rottey (UGent)

(2021) IMMUNOTHERAPY. 13(5). p.409-418
Add to list
A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases

Yanina Jansen, Vibeke Kruse (UGent) , Jurgen Corthals, Kelly Schats, Pieter-Jan van Dam, Teofila Seremet, Carlo Heirman, Lieve Brochez (UGent) , Mark Kockx, Kris Thielemans, et al.

(2020) CANCER IMMUNOLOGY IMMUNOTHERAPY. 69(12). p.2589-2598
Add to list
- Miscellaneous
- open access
Recommendations for skin cancer consultation and surgery during COVID‐19 pandemic

Lieve Brochez (UGent) , J.F. Baurain, V. Del Marmol, A. Nikkels, Vibeke Kruse (UGent) , F. Sales, M. Stas, A. Van Laethem and M. Garmyn

(2020) JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY. 34(9). p.1876-1878
Add to list
Phase 2 trial of nivolumab combined with stereotactic body radiation therapy in patients with metastatic or locally advanced inoperable melanoma

Nora Sundahl, Teofila Seremet, Jo Van Dorpe (UGent) , Bart Neyns, Liesbeth Ferdinande, Annabel Meireson (UGent) , Lieve Brochez (UGent) , Vibeke Kruse (UGent) and Piet Ost (UGent)

(2019) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 104(4). p.828-835

1
2
3

Next →